Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions
Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions
نویسندگان: لیلا حسینی , منوچهر سیدی وفایی , جواد محمودی , رضا بدل زاده
کلمات کلیدی: Aging Ischemic disorders
Nicotinamide adenine dinucleotide Nicotinamide
mononucleotide Mitochondria Longevity
نشریه: 4587 , 4 , 20 , 2019
| نویسنده ثبت کننده مقاله |
رضا بدل زاده |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات کاربردی دارویی |
| کد مقاله |
67599 |
| عنوان فارسی مقاله |
Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions |
| عنوان لاتین مقاله |
Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions |
| ناشر |
4 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Abstract Nicotinamide adenine dinucleotide
(NAD?) has been described as central coenzyme of
redox reactions and is a key regulator of stress
resistance and longevity. Aging is a multifactorial
and irreversible process that is characterized by a
gradual diminution in physiological functions in an
organism over time, leading to development of ageassociated
pathologies and eventually increasing the
probability of death. Ischemia is the lack of nutritive
blood flow that causes damage and mortality that
mostly occurs in various organs during aging. During
the process of aging and related ischemic conditions,
NAD? levels decline and lead to nuclear and mitochondrial
dysfunctions, resulting in age-related
pathologies. The majority of studies have shown that
restoring of NAD? using supplementation with intermediates
such as nicotinamide mononucleotide and
nicotinamide riboside can be a valuable strategy for
recovery of ischemic injury and age-associated
defects. This review summarizes the molecular mechanisms
responsible for the reduction in NAD? levels
during ischemic disorders and aging, as well as a
particular focus is given to the recent progress in the
understanding of NAD? precursor’s effects on aging
and ischemia. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 2019- Biogeron---- Nicotinamide adenine dinucleotide emerges as a therapeutic.pdf | 1398/04/05 | 579786 | دانلود |